CD200 (OX-2 Membrane Glycoprotein) Expression in B Cell-Derived Neoplasms

被引：51

作者：

Dorfman, David M. ^{[1
]}

Shahsafaei, Aliakbar

机构：

[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA

来源：

AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2010年 / 134卷 / 05期

关键词：

Chronic lymphocytic leukemia/small lymphocytic lymphoma; Classical Hodgkin lymphoma; Nodular lymphocyte predominant Hodgkin lymphoma; THERAPEUTIC TARGET; PROGNOSTIC-FACTOR; DIAGNOSIS; LYMPHOMA; HELP;

D O I：

10.1309/AJCP38XRRUGSQOVC

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

We studied the expression of CD200, an immunoglobulin supelfamily membrane glycoprotein, in a wide range of B cell derived neoplasms by immunohistochemical staining of paraffin-embedded tissue sections. In addition to chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), CD200 is expressed in other B-cell lymphoproliferative disorders, including hairy cell leukemia. In addition, neoplastic cells in classical Hodgkin lymphoma are immunoreactive for CD200. CD200 was previously reported to be expressed in acute myeloid leukemia, and we find that it is also expressed in B-lymphoblastic leukemia/lymphoma. We conclude that CD200 may be a useful immunophenotypic marker in the evaluation of B cell derived neoplasms. Furthermore, since an anti-CD200 immunotherapeutic agent is in clinical trials, a number of B cell derived neoplasms in addition to CLL/SLL may be suitable therapeutic targets.

引用

页码：726 / 733

页数：8

共 20 条

[1] CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells [J].

Brunetti, Lorenzo ;

Di Noto, Rosa ;

Abate, Giovanna ;

Gorrese, Marisa ;

Gravetti, Angela ;

Raia, Maddalena ;

Scalia, Giulia ;

Pascariello, Caterina ;

Camera, Andrea ;

Del Vecchio, Luigi .

BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (05) :665-667

[2] T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells [J].

Chtanova, T ;

Tangye, SG ;

Newton, R ;

Frank, N ;

Hodge, MR ;

Rolph, MS ;

Mackay, CR .

JOURNAL OF IMMUNOLOGY, 2004, 173 (01) :68-78

[3] Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma [J].

Dorfman, DM ;

Brown, JA ;

Shahsafaei, A ;

Freeman, GJ .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (07) :802-810

[4] Loss of expression of the WNT/β-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas [J].

Dorfman, DM ;

Greisman, HA ;

Shahsafaei, A .

AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) :1539-1544

[5] Down-regulation of the macrophage lineage through interaction with OX2 (CD200) [J].

Hoek, RM ;

Ruuls, SR ;

Murphy, CA ;

Wright, GJ ;

Goddard, R ;

Zurawski, SM ;

Blom, B ;

Homola, ME ;

Streit, WJ ;

Brown, MH ;

Barclay, AN ;

Sedgwick, JD .

SCIENCE, 2000, 290 (5497) :1768-1771

[6] Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression [J].

Kretz-Rommel, Anke ;

Bowdish, Katherine S. .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (01) :5-15

[7] CD200 expression on tumor cells suppresses antitumor immunity: New approaches to cancer immunotherapy [J].

Kretz-Rommel, Anke ;

Qin, Fenghua ;

Dakappagari, Naveen ;

Ravey, E. Prenn ;

McWhirter, John ;

Oltean, Daniela ;

Frederickson, Shana ;

Maruyama, Toshiaki ;

Wild, Martha A. ;

Nolan, Mary-Jean ;

Wu, Dayang ;

Springhorn, Jeremy ;

Bowdish, Katherine S. .

JOURNAL OF IMMUNOLOGY, 2007, 178 (09) :5595-5605

[8] Blockade of CD200 in the presence or absence of antibody effector function: Implications for anti-CD200 therapy [J].

Kretz-Ronlmel, Anke ;

Qin, Fenghua ;

Dakappagari, Naveen ;

Cofiell, Roxanne ;

Faas, Susan J. ;

Bowdish, Katherine S. .

JOURNAL OF IMMUNOLOGY, 2008, 180 (02) :699-705

[9] CHARACTERIZATION OF THE HUMAN HOMOLOG OF THE RAT MRC OX-2 MEMBRANE GLYCOPROTEIN [J].

MCCAUGHAN, GW ;

CLARK, MJ ;

BARCLAY, AN .

IMMUNOGENETICS, 1987, 25 (05) :329-335

[10] Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation [J].

McWhirter, JR ;

Kretz-Rommel, A ;

Saven, A ;

Maruyama, T ;

Potter, KN ;

Mockridge, CI ;

Ravey, EP ;

Qin, FH ;

Bowdish, KS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (04) :1041-1046

← 1 2 →